Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,937
datasets available to search
ShareScore release 0.9.0
Dataset results
2,937 results for “Multiple Myeloma”
First-in-human Single Agent Study of SAR442085 in Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT04000282. IPD Sharing: YES. Countries: 6. Publications: 1.
Tandem Auto Stem Cell Transplant With Melphalan Followed by Melphalan and Bortezomib in Patients With Multiple Myeloma
ClinicalTrials.gov study NCT01241708. IPD Sharing: Not stated. Countries: 1. Publications: 55.
Daratumumab (HuMax®-CD38) Safety Study in Multiple Myeloma
ClinicalTrials.gov study NCT00574288. IPD Sharing: Not stated. Countries: 4. Publications: 6.
Descartes-11 in Patients With Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT03994705. IPD Sharing: NO. Countries: 1. Publications: 7.
Clinical and Sociodemographic Characterization of Multiple Myeloma Participants With Symptomatic Relapse and/or Refractory Disease in Spain (CharisMMa Study)
ClinicalTrials.gov study NCT03188536. IPD Sharing: YES. Countries: 1. Publications: 2.
Dendritic Cell/Myeloma Fusion Vaccine for Multiple Myeloma (BMT CTN 1401)
ClinicalTrials.gov study NCT02728102. IPD Sharing: YES. Countries: 1. Publications: 1.
Study of Multiple Myeloma Patients Relapsing or Progressing After Autologous Transplantation on Total Therapy 2
ClinicalTrials.gov study NCT00573391. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of Daratumumab With Pomalidomide, Dexamethasone, and All-Transretinoic Acid in Patients With Multiple Myeloma
ClinicalTrials.gov study NCT04700176. IPD Sharing: NO. Countries: 1. Publications: 17.
Ixazomib With Cyclophosphamide and Dexamethasone in Patients With Previously Untreated Symptomatic Multiple Myeloma or Light Chain Amyloidosis
ClinicalTrials.gov study NCT01864018. IPD Sharing: Not stated. Countries: 1. Publications: 1.
S0204 Thalidomide, Chemotherapy, and Peripheral Stem Cell Transplant in Treating Patients With Multiple Myeloma
ClinicalTrials.gov study NCT00040937. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Bendamustine, Wkly Bortezomib, Lenalidomide and Dexamethasone for Multiple Myeloma
ClinicalTrials.gov study NCT01484626. IPD Sharing: NO. Countries: 1. Publications: 43.
A Study of Combination of Daratumumab and Velcade (Bortezomib) Melphalan-Prednisone (DVMP) Compared to Velcade Melphalan-Prednisone (VMP) in Participants With Previously Untreated Multiple Myeloma
ClinicalTrials.gov study NCT02195479. IPD Sharing: Not stated. Countries: 24. Publications: 7.
High-Dose Sequential Therapy and Single Autologous Transplantation for Multiple Myeloma
ClinicalTrials.gov study NCT00349778. IPD Sharing: NO. Countries: 1. Publications: 1.
Phase 1b Study of Weekly Carfilzomib in Combination With Lenalidomide and Dexamethasone in Subjects With Multiple Myeloma
ClinicalTrials.gov study NCT02335983. IPD Sharing: NO. Countries: 1. Publications: 1.
Bortezomib, Doxorubicin Hydrochloride Liposome, and Dexamethasone Followed by Thalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Multiple Myeloma
ClinicalTrials.gov study NCT00458705. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Autologous or Syngeneic Stem Cell Transplant Followed by Donor Stem Cell Transplant and Bortezomib in Treating Patients With Newly Diagnosed High-Risk, Relapsed, or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT00793572. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Once-weekly Versus Twice-weekly Carfilzomib in Combination With Dexamethasone in Adults With Relapsed and Refractory Multiple Myeloma
ClinicalTrials.gov study NCT02412878. IPD Sharing: Not stated. Countries: 20. Publications: 7.
CC-4047 and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma or Amyloidosis
ClinicalTrials.gov study NCT00558896. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Pomalidomide in Combination With Low-dose Dexamethasone or Pomalidomide in Combination With Low-dose Dexamethasone and Daratumumab in Subjects With Relapsed or Refractory Multiple Myeloma Following Le
ClinicalTrials.gov study NCT01946477. IPD Sharing: Not stated. Countries: 4. Publications: 4.
A Study of the Safety and Efficacy of CNTO 328 and Bortezomib to Bortezomib Alone in Patients With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT00401843. IPD Sharing: Not stated. Countries: 18. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.